ConductScience.org, home

Trial · NCT02111746

Registered outcomes14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPostoperative Pain as Assessed by a Numeric Pain Scale (NPS)postoperative day 1The Numeric Pain Scale (NPS) ranges from 0 ("no pain") to 10 ("worst possible pain").
PrimaryPostoperative Pain as Assessed by a Numeric Pain Scale (NPS)postoperative day 2The Numeric Pain Scale (NPS) ranges from 0 ("no pain") to 10 ("worst possible pain").
PrimaryPostoperative Pain as Assessed by a Numeric Pain Scale (NPS)postoperative day 3The Numeric Pain Scale (NPS) ranges from 0 ("no pain") to 10 ("worst possible pain").
PrimaryPostoperative Pain as Assessed by a Five-point Satisfaction Scalepostoperative day 1The 5-point satisfaction scale ranges from 1 (extremely dissatisfied) to 5 (extremely satisfied).
PrimaryPostoperative Pain as Assessed by a Five-point Satisfaction Scalepostoperative day 2The 5-point satisfaction scale ranges from 1 (extremely dissatisfied) to 5 (extremely satisfied).
PrimaryPostoperative Pain as Assessed by a Five-point Satisfaction Scalepostoperative day 3The 5-point satisfaction scale ranges from 1 (extremely dissatisfied) to 5 (extremely satisfied).
PrimaryPostoperative Pain as Assessed by the Brief Pain Inventory (BPI)postoperative day 1The Brief Pain Inventory (BPI) ranges from 0 ("no pain") to 10 ("worst pain you can imagine").
PrimaryPostoperative Pain as Assessed by the Brief Pain Inventory (BPI)postoperative day 2The Brief Pain Inventory (BPI) ranges from 0 ("no pain") to 10 ("worst pain you can imagine").
PrimaryPostoperative Pain as Assessed by the Brief Pain Inventory (BPI)postoperative day 3The Brief Pain Inventory (BPI) ranges from 0 ("no pain") to 10 ("worst pain you can imagine").
SecondaryOverall Opioid UseOver the first 72 hours after surgeryThe total amount in mg of opioid medication consumed through 12, 24, 36, 48, 60, and 72 hours after surgery will be assessed.
SecondaryMean Length of Hospital StayParticipants will be followed for the duration of hospital stay, an expected average of 4 weeks
Indirect outcome measure to assess the adequacy of postoperative pain control as an indicator of improvement in healing period, patient participation in physical therapy and faster patient mobilization, and overall health care cost
SecondaryChange From Baseline in Quality of LifeWill be assessed preoperatively, on the first post-op day (POD 1), on POD2, and POD 3
The impact of pain on patient's quality of life will be assessed through a brief pain inventory (BPI). In addition, the 5-point scale analgesia satisfaction survey will be used along with the BPI to assess patient satisfaction and quality of life.
SecondaryNumber of Participants Who Attain Physical Therapy Goal That Justifies Discharge From Inpatient Physical Therapy Within 72 Hours72 hours after surgery
SecondaryHospital Cost for Patient Care During Hospitalizationduration of hospital stay, an expected average of 4 weeksHospital cost for patient care during hospitalization will be estimated from hospital charges and financial records.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02111746/registered